{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:10:57Z","timestamp":1788829857189,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Seoul National University Hospital Research Fund","award":["04-2018-0860"],"award-info":[{"award-number":["04-2018-0860"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Several genetic variants are known to be associated with nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the longitudinal associations between genetic variants and NAFLD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed a genome-wide association study (GWAS) in Korean individuals who underwent repeated health check-ups. NAFLD was defined by ultrasonography and exclusion of secondary causes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The subjects had a median age of 50.0\u2009years, and 54.8% were male. The median follow-up duration was 39\u2009months. Among the 3905 subjects without NAFLD at baseline, 874 (22.4%) subjects developed NAFLD, and among the 1818 subjects with NAFLD at baseline, NAFLD regressed in 336 (18.5%) subjects during the follow-up period. After adjusting for age, sex and body mass index, no single-nucleotide polymorphism (SNP) passed Bonferroni correction for genome-wide significance in the development or regression of NAFLD. Among the SNPs that passed the genome-wide suggestiveness threshold (<jats:italic>p<\/jats:italic>\u2009=\u20091E-04) in the discovery set in the GWAS, only 1 SNP (rs4906353) showed an association with the development of NAFLD, with marginal significance in the validation set (<jats:italic>p<\/jats:italic>-value, discovery set\u2009=\u20099.68E-5 and validation set\u2009=\u20090.00531).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This exploratory study suggests that longitudinal changes in NAFLD are not associated with genetic variants in the Korean population. These findings provide new insight into genetic mechanisms in the pathogenesis of NAFLD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12876-020-01469-8","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T20:02:46Z","timestamp":1602792166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-7737","authenticated-orcid":false,"given":"Goh Eun","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunsoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Sun","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong","family":"In Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Yoon","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865\u201373.","journal-title":"Hepatology"},{"key":"1469_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113\u201321.","journal-title":"Gastroenterology"},{"key":"1469_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7:234\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1469_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1469_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11892-008-0027-9","volume":"8","author":"NM Wilfred de Alwis","year":"2008","unstructured":"Wilfred de Alwis NM, Day CP. Genes and nonalcoholic fatty liver disease. Curr Diab Rep. 2008;8:156\u201363.","journal-title":"Curr Diab Rep"},{"key":"1469_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/hep.21631","volume":"45","author":"R Gambino","year":"2007","unstructured":"Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology. 2007;45:1097\u2013107.","journal-title":"Hepatology"},{"key":"1469_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2016.0109","volume":"23","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ. Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2017;23:1\u201312.","journal-title":"Clin Mol Hepatol"},{"key":"1469_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53:1883\u201394.","journal-title":"Hepatology"},{"key":"1469_CR11","doi-asserted-by":"publisher","first-page":"e38322","DOI":"10.1371\/journal.pone.0038322","volume":"7","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Sumida Y, Umemura A, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7:e38322.","journal-title":"PLoS One"},{"key":"1469_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl17306","volume":"12","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee Y, Yim JY, et al. Genetic polymorphisms of PNPLA3 and SAMM50 are associated with nonalcoholic fatty liver disease in a Korean population. Gut Liver. 2018;12:316\u201323.","journal-title":"Gut Liver"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00439-013-1294-3","volume":"132","author":"T Kitamoto","year":"2013","unstructured":"Kitamoto T, Kitamoto A, Yoneda M, et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132:783\u201392.","journal-title":"Hum Genet"},{"key":"1469_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/CEJ.0000000000000359","volume":"27","author":"EK Choe","year":"2018","unstructured":"Choe EK, Lee Y, Cho JY, et al. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population. Eur J Cancer Prev. 2018;27:453\u201360.","journal-title":"Eur J Cancer Prev"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3350\/cmh.2016.22.1.146","volume":"22","author":"GE Chung","year":"2016","unstructured":"Chung GE, Kim D, Kwak MS, et al. The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2016;22:146\u201351.","journal-title":"Clin Mol Hepatol"},{"key":"1469_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","volume":"137","author":"D Prati","year":"2002","unstructured":"Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1\u201310.","journal-title":"Ann Intern Med"},{"key":"1469_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiologica l imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745\u201350.","journal-title":"Gastroenterology"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","volume":"292","author":"SH Saverymuttu","year":"1986","unstructured":"Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292:13\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1469_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"1000 Genomes Project Consortium, Abecasis GR, Altshuler D, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061\u201373.","journal-title":"Nature"},{"key":"1469_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/hep.23759","volume":"52","author":"Y Rotman","year":"2010","unstructured":"Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, Nash CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology. 2010;52:894\u2013903.","journal-title":"Hepatology"},{"key":"1469_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2350-11-172","volume":"11","author":"K Hotta","year":"2010","unstructured":"Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010;11:172.","journal-title":"BMC Med Genet"},{"key":"1469_CR22","doi-asserted-by":"crossref","unstructured":"Parisinos CA, Wilman HR, Thomas EL, et al. Genome-wide and Mendelian Randomisation Studies of Liver MRI Yield Insights Into the Pathogenesis of Steatohepatitis. J Hepatol. 2020;73:241\u201351.","DOI":"10.1016\/j.jhep.2020.03.032"},{"key":"1469_CR23","first-page":"574","volume":"2014","author":"P Pingitore","year":"1841","unstructured":"Pingitore P, Pirazzi C, Mancina RM, et al. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. Biochim Biophys Acta. 1841;2014:574\u201380.","journal-title":"Biochim Biophys Acta"},{"key":"1469_CR24","doi-asserted-by":"publisher","first-page":"e39362","DOI":"10.1371\/journal.pone.0039362","volume":"7","author":"CN Palmer","year":"2012","unstructured":"Palmer CN, Maglio C, Pirazzi C, et al. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS One. 2012;7:e39362.","journal-title":"PLoS One"},{"key":"1469_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"JE Kozlitina","year":"2014","unstructured":"Kozlitina JE, Smagris S, Stender BG, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46:352\u20136.","journal-title":"Nat Genet"},{"key":"1469_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep.27556","volume":"61","author":"S Sookoian","year":"2015","unstructured":"Sookoian S, Casta\u00f1o GO, Scian R, et al. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology. 2015;61:515\u201325.","journal-title":"Hepatology"},{"key":"1469_CR27","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150:1219\u201330.","journal-title":"Gastroenterology"},{"key":"1469_CR28","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch S, Stickel F, Tr\u00e9po E, et al. A Genome-Wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47:1443\u20138.","journal-title":"Nat Genet"},{"key":"1469_CR29","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/hep.30350","volume":"69","author":"Y Ma","year":"2019","unstructured":"Ma Y, Belyaeva OV, Philip M. Brown, et al. HSD17B13 is a hepatic retinol dehydrogenase associated with histological features of non-alcoholic fatty liver disease. Hepatology. 2019;69:1504\u201319.","journal-title":"Hepatology."},{"key":"1469_CR30","doi-asserted-by":"crossref","unstructured":"Krawczyk M, Rau M, J\u00f6rn M. Schattenberg, et al. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. Lipid Res. 2017;58:247\u201355.","DOI":"10.1194\/jlr.P067454"},{"key":"1469_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3945\/ajcn.111.012369","volume":"94","author":"K Sevastianova","year":"2011","unstructured":"Sevastianova K, Kotronen A, Gastaldelli A, et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr. 2011;94:104\u201311.","journal-title":"Am J Clin Nutr"},{"key":"1469_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jgh.12656","volume":"30","author":"J Shen","year":"2015","unstructured":"Shen J, Wong GL, Chan HL, et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2015;30:139\u201346.","journal-title":"J Gastroenterol Hepatol"},{"key":"1469_CR33","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","volume":"150","author":"QM Anstee","year":"2016","unstructured":"Anstee QM, Seth D, Day CP. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology. 2016;150:1728\u201344 e7.","journal-title":"Gastroenterology"},{"key":"1469_CR34","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324.","journal-title":"PLoS Genet"},{"issue":"9","key":"1469_CR35","doi-asserted-by":"publisher","first-page":"e74089","DOI":"10.1371\/journal.pone.0074089","volume":"8","author":"S Petta","year":"2013","unstructured":"Petta S, Valenti L, Marchesini G, Di Marco V, et al. PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One. 2013;8(9):e74089.","journal-title":"PLoS One"},{"key":"1469_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/hep.27643","volume":"62","author":"G Musso","year":"2015","unstructured":"Musso G, Cassader M, Gambino R. PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease. Hepatology. 2015;62:658\u20139.","journal-title":"Hepatology."},{"key":"1469_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ije\/dyr178","volume":"41","author":"OA Panagiotou","year":"2012","unstructured":"Panagiotou OA, Ioannidis JP, Genome-Wide SP. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol. 2012;41:273\u201386.","journal-title":"Int J Epidemiol"},{"key":"1469_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/gepi.20292","volume":"32","author":"CJ Hoggart","year":"2008","unstructured":"Hoggart CJ, Clark TG, De Iorio M, Whittaker JC, Balding DJ. Genome-wide significance for dense SNP and resequencing data. Genet Epidemiol. 2008;32:179\u201385.","journal-title":"Genet Epidemiol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01469-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T14:36:43Z","timestamp":1634308603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01469-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01469-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"29 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Seoul National University Hospital with a waiver of informed consent (No. 1705\u2013113-855).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}